ATE441425T1 - Cerebrospinal und vaskulär wirksame pharmazeutische zubereitung und verfahren zu ihrer herstellung - Google Patents
Cerebrospinal und vaskulär wirksame pharmazeutische zubereitung und verfahren zu ihrer herstellungInfo
- Publication number
- ATE441425T1 ATE441425T1 AT99909670T AT99909670T ATE441425T1 AT E441425 T1 ATE441425 T1 AT E441425T1 AT 99909670 T AT99909670 T AT 99909670T AT 99909670 T AT99909670 T AT 99909670T AT E441425 T1 ATE441425 T1 AT E441425T1
- Authority
- AT
- Austria
- Prior art keywords
- cerebrospinal
- vascular
- pharmaceutical preparation
- production
- cyclosporin
- Prior art date
Links
- 239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
- 230000002792 vascular Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 2
- 229930105110 Cyclosporin A Natural products 0.000 abstract 2
- 108010036949 Cyclosporine Proteins 0.000 abstract 2
- 229960001265 ciclosporin Drugs 0.000 abstract 2
- 229930182912 cyclosporin Natural products 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1999/004359 WO2000050058A1 (en) | 1999-02-26 | 1999-02-26 | Cerebrospinal and vascular pharmaceutical composition and process for preparing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE441425T1 true ATE441425T1 (de) | 2009-09-15 |
Family
ID=22272265
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99909670T ATE441425T1 (de) | 1999-02-26 | 1999-02-26 | Cerebrospinal und vaskulär wirksame pharmazeutische zubereitung und verfahren zu ihrer herstellung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7446093B1 (de) |
| EP (1) | EP1091750B1 (de) |
| AT (1) | ATE441425T1 (de) |
| AU (1) | AU2882599A (de) |
| CA (1) | CA2330329C (de) |
| CY (1) | CY1109563T1 (de) |
| DE (1) | DE69941359D1 (de) |
| DK (1) | DK1091750T3 (de) |
| ES (1) | ES2332390T3 (de) |
| PT (1) | PT1091750E (de) |
| WO (1) | WO2000050058A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002078670A1 (en) * | 2001-03-02 | 2002-10-10 | Neuron Therapeutics, Inc. | Neuroprotectants formulations and methods |
| GB0329498D0 (en) * | 2003-12-19 | 2004-01-28 | Novartis Ag | Organic compounds |
| US10123969B2 (en) | 2015-10-15 | 2018-11-13 | Wisconsin Alumni Research Foundation | Osmotic enhancement of drug/therapeutic delivery to the brain following infusion or injection into the cerebrospinal fluid |
| US20220151922A1 (en) * | 2020-11-17 | 2022-05-19 | Greg Eckel | Medication for Alleviating Parkinson's Symptoms and Method of Administering |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649047A (en) * | 1985-03-19 | 1987-03-10 | University Of Georgia Research Foundation, Inc. | Ophthalmic treatment by topical administration of cyclosporin |
| CH679119A5 (de) * | 1988-05-13 | 1991-12-31 | Sandoz Ag | |
| US5221607A (en) * | 1989-09-18 | 1993-06-22 | Scios Nova Inc. | Assays and reagents for amyloid deposition |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5252463A (en) * | 1990-06-22 | 1993-10-12 | The Du Pont Merck Pharmaceutical Company | Clipsin, a chymotrypsin-like protease and method of using same |
-
1999
- 1999-02-26 CA CA002330329A patent/CA2330329C/en not_active Expired - Fee Related
- 1999-02-26 ES ES99909670T patent/ES2332390T3/es not_active Expired - Lifetime
- 1999-02-26 WO PCT/US1999/004359 patent/WO2000050058A1/en not_active Ceased
- 1999-02-26 DE DE69941359T patent/DE69941359D1/de not_active Expired - Lifetime
- 1999-02-26 PT PT99909670T patent/PT1091750E/pt unknown
- 1999-02-26 AT AT99909670T patent/ATE441425T1/de active
- 1999-02-26 DK DK99909670T patent/DK1091750T3/da active
- 1999-02-26 EP EP99909670A patent/EP1091750B1/de not_active Expired - Lifetime
- 1999-02-26 AU AU28825/99A patent/AU2882599A/en not_active Abandoned
-
2000
- 2000-02-26 US US09/674,092 patent/US7446093B1/en not_active Expired - Fee Related
-
2009
- 2009-12-01 CY CY20091101256T patent/CY1109563T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000050058A1 (en) | 2000-08-31 |
| EP1091750B1 (de) | 2009-09-02 |
| CA2330329A1 (en) | 2000-08-31 |
| EP1091750A1 (de) | 2001-04-18 |
| EP1091750A4 (de) | 2005-04-13 |
| DE69941359D1 (de) | 2009-10-15 |
| ES2332390T3 (es) | 2010-02-03 |
| CA2330329C (en) | 2009-08-25 |
| DK1091750T3 (da) | 2009-12-21 |
| AU2882599A (en) | 2000-09-14 |
| PT1091750E (pt) | 2009-11-10 |
| US7446093B1 (en) | 2008-11-04 |
| CY1109563T1 (el) | 2014-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50003555D1 (de) | Indanylsubstituierte benzolcarbonamide, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltende pharmazeutische zubereitungen | |
| DE58904479D1 (de) | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung. | |
| BR9806870B1 (pt) | composto amidino, formulação farmacêutica, uso de um composto, e, processo papa preparar o mesmo. | |
| DE69016125D1 (de) | Chinolin-Derivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel. | |
| DE69410470D1 (de) | Modifiziertes konjugiertes diencopolymer, verfahren zu dessen herstellung und zusammensetzung daraus | |
| EP0983994A3 (de) | Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe | |
| DE59008160D1 (de) | Feste pharmazeutische Präparate und Verfahren zu ihrer Herstellung. | |
| ATE285754T1 (de) | Pharmazeutische zusammensetzung mit lyophilisierten lyposomen welche einen unlöslichen aktiven wirkstoff einschliessen, verfahren zu dessen herstellung | |
| DE69909209D1 (de) | Pyrimidinon-derivate, diese verbindungen enthaltenden pharmazeutische zubereitungen und verfharen zu ihrer herstellung | |
| DE3874358D1 (de) | 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen. | |
| ATE210638T1 (de) | Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
| ATE294175T1 (de) | 4-sulfonamid-piperidin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen | |
| ATE264837T1 (de) | N-guanidinalkylamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische präparate | |
| DE59912402D1 (de) | Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| ATE222586T1 (de) | Benzolsulfonamidderivate und verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
| CY1109563T1 (el) | Φαρμακευτικη συνθεση για εγκεφαλονωτιαια και αγγειακη εφαρμογη και μεθοδος για την παρασκευη της | |
| ATE137745T1 (de) | Arylpyrrol enthaltende insekticidale, acaricidale und nematicidale mittel sowie verfahren zu ihrer herstellung | |
| ATE244246T1 (de) | Pyridothienodiazepine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
| DE60006201D1 (de) | 4-Oxatricyclo(4.3.1.1-3,8)undecan-5-on-Derivate und Verfahren zu ihrer Herstellung | |
| DE50006026D1 (de) | Wirkstoffhaltiges implantat-baustein-system und verfahren zu dessen herstellung | |
| DE69021602D1 (de) | N-substituierte-3-Hydrazino-benzenesulfonamid-Derivate, Verfahren zu ihrer Herstellung und herbizide Mittel. | |
| DE59902408D1 (de) | Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament | |
| DE69931038D1 (de) | Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten | |
| DE50000560D1 (de) | Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| DE3867075D1 (de) | 2-alkylsulfinyl-4(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1091750 Country of ref document: EP |
|
| UEP | Publication of translation of european patent specification |
Ref document number: 1091750 Country of ref document: EP |